1. Home
  2. EYPT vs BAND Comparison

EYPT vs BAND Comparison

Compare EYPT & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • BAND
  • Stock Information
  • Founded
  • EYPT 1987
  • BAND 2000
  • Country
  • EYPT United States
  • BAND United States
  • Employees
  • EYPT N/A
  • BAND N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • BAND Computer Software: Prepackaged Software
  • Sector
  • EYPT Industrials
  • BAND Technology
  • Exchange
  • EYPT Nasdaq
  • BAND Nasdaq
  • Market Cap
  • EYPT 489.4M
  • BAND 495.2M
  • IPO Year
  • EYPT 2005
  • BAND 2017
  • Fundamental
  • Price
  • EYPT $6.15
  • BAND $17.00
  • Analyst Decision
  • EYPT Strong Buy
  • BAND Buy
  • Analyst Count
  • EYPT 8
  • BAND 8
  • Target Price
  • EYPT $25.71
  • BAND $27.43
  • AVG Volume (30 Days)
  • EYPT 886.1K
  • BAND 355.6K
  • Earning Date
  • EYPT 03-06-2025
  • BAND 02-20-2025
  • Dividend Yield
  • EYPT N/A
  • BAND N/A
  • EPS Growth
  • EYPT N/A
  • BAND N/A
  • EPS
  • EYPT N/A
  • BAND N/A
  • Revenue
  • EYPT $45,713,000.00
  • BAND $748,487,000.00
  • Revenue This Year
  • EYPT N/A
  • BAND $25.91
  • Revenue Next Year
  • EYPT N/A
  • BAND $3.05
  • P/E Ratio
  • EYPT N/A
  • BAND N/A
  • Revenue Growth
  • EYPT 7.50
  • BAND 24.52
  • 52 Week Low
  • EYPT $5.90
  • BAND $11.90
  • 52 Week High
  • EYPT $29.31
  • BAND $25.02
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 36.22
  • BAND 42.02
  • Support Level
  • EYPT $5.90
  • BAND $15.80
  • Resistance Level
  • EYPT $6.67
  • BAND $19.88
  • Average True Range (ATR)
  • EYPT 0.71
  • BAND 0.89
  • MACD
  • EYPT -0.04
  • BAND -0.10
  • Stochastic Oscillator
  • EYPT 8.99
  • BAND 29.41

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to large as well as small and medium-sized business, customers and is generally derived from usage and service fees. Usage revenue includes voice communication (driven by inbound and outbound minutes and toll-free minutes) and messaging communication (driven by the number of messages) that traverse the platform and network. Service fees include the provision and management of phone numbers and emergency services access.

Share on Social Networks: